cabg
353 показвания
2 обсъждат
Популярни
Последни
🚨 BIG STEP FOR $HUMA 🚨
Humacyte just published preclinical data in JACC: Basic to Translational Science showing its Coronary Tissue Engineered Vessel (CTEV) stayed 100% patent at 6 months in primates, recellularized with host cells, and remodeled to match native arteries.
👉 IND filing for first-in-human CABG trial planned Q4 2025. 🔥
💡 CABG is one of the world’s largest unmet needs—current saphenous vein grafts fail ~50% at 10 years. CTEV could be a true game changer.
#Biotech #Humacyte #CABG #MedicalInnovation
Humacyte just published preclinical data in JACC: Basic to Translational Science showing its Coronary Tissue Engineered Vessel (CTEV) stayed 100% patent at 6 months in primates, recellularized with host cells, and remodeled to match native arteries.
👉 IND filing for first-in-human CABG trial planned Q4 2025. 🔥
💡 CABG is one of the world’s largest unmet needs—current saphenous vein grafts fail ~50% at 10 years. CTEV could be a true game changer.
#Biotech #Humacyte #CABG #MedicalInnovation
Влезте, за да разгледате още съдържание